These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 4298568

  • 41. [Microflora of the upper respiratory tract and state of immunity in patients with chronic tonsillitis treated with prodigiozan combined with antibiotics].
    Golosova GV, Anikina TP, Skurkovich GV.
    Antibiotiki; 1970 Oct; 15(10):946-50. PubMed ID: 4922626
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Comparative study of the chemotherapeutic effect of paromomycin and monomycin in experimental cutaneous leischmaniasis in albino mice].
    Moskalenko NIu, Pershin GN.
    Farmakol Toksikol; 1966 Oct; 29(1):90-4. PubMed ID: 4864948
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Clinical characteristics of prodigiozan-provoked exacerbation or chronic salpingo-oophoritis].
    Strugatskiĭ VM, Rastorgueva VM, Tsoĭ S.
    Akush Ginekol (Mosk); 1987 Nov; (11):35-7. PubMed ID: 3439565
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Nonspecific stimulation of the body's natural resistance to infection with prodigiozan].
    Bukharin OV.
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Sep; 43(9):54-8. PubMed ID: 4981249
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [On prevention of influenza with prodigiozan].
    Popov NV.
    Voen Med Zh; 1969 Feb; 2():48. PubMed ID: 4890725
    [No Abstract] [Full Text] [Related]

  • 51. [Use of sodium nucleinate and its combinations with bacterial polysaccharides for preventing the nephrotoxic action of aminoglycoside antibiotics].
    Salakaia RG, Amirian NB.
    Antibiotiki; 1984 Jul; 29(7):507-9. PubMed ID: 6486749
    [Abstract] [Full Text] [Related]

  • 52. [Use of prodigiozan in the complex therapy of dysentery].
    Pokrovskiĭ VI, Mashilov VP, Utekhin VA, Iushchuk ND, Kasatskaia LK.
    Vrach Delo; 1973 Apr; 4():154-6. PubMed ID: 4576250
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Activity of prodigiozan by various routes of administration and during non-specific stimulation of local (regional) defense mechanisms].
    Givental' NI.
    Antibiotiki; 1971 Apr; 16(4):345-50. PubMed ID: 4936028
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Treatment of irradiated guinea pigs with the polysaccharide prodigiozan].
    Chertkov KS, Mosina ZM, Khramchenkova SP.
    Radiobiologiia; 1976 Apr; 16(1):88-91. PubMed ID: 775528
    [No Abstract] [Full Text] [Related]

  • 58. [Use of prodigiozan in treating vibration disease].
    Balan GM, Cherkasskaia RG.
    Gig Tr Prof Zabol; 1977 Apr; (4):32-6. PubMed ID: 323109
    [No Abstract] [Full Text] [Related]

  • 59. [On the use of prodigiosan in combination with antibiotics for the treatment of acute and chronic inflammatory diseases of the cerebral membranes].
    Mad'iarov SD.
    Antibiotiki; 1969 Jan; 14(1):86-9. PubMed ID: 4889840
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.